Holen Sie sich die Stockscreener-App
73.38
2.41%
1.73
Schlusskurs vom Vortag:
$71.65
Offen:
$71.86
24-Stunden-Volumen:
1.68M
Relative Volume:
1.28
Marktkapitalisierung:
$12.71B
Einnahmen:
$8.35B
Nettoeinkommen (Verlust:
$1.56B
KGV:
8.2693
EPS:
8.8738
Netto-Cashflow:
$-4.00M
1W Leistung:
+10.13%
1M Leistung:
+12.46%
6M Leistung:
+2.60%
1J Leistung:
+10.13%
1-Tages-Spanne:
$71.50
$73.40
1-Wochen-Bereich:
$66.26
$73.40
52-Wochen-Spanne:
$62.38
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
1750 YANKEE DOODLE ROAD, EAGAN
Compare SOLV vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
73.38 | 12.71B | 8.35B | 1.56B | -4.00M | 8.8738 |
ISRG
Intuitive Surgical Inc
|
450.06 | 159.39B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
149.43 | 41.17B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
39.52 | 33.42B | 29.14B | 1.07B | 1.52B | 1.1995 |
ALC
Alcon Inc
|
62.56 | 30.51B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
206.76 | 29.99B | 5.54B | 1.52B | 1.74B | 10.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-24 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2026-01-26 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2026-01-20 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum Q1 FY26 slides: EPS beats forecast, margins expand to 19.5% - Investing.com India
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Solventum stock is recovering: What's going on? - MSN
Earnings call transcript: Solventum Q1 2026 earnings beat expectations - Investing.com UK
Earnings call transcript: Solventum Q1 2026 earnings beat expectations By Investing.com - Investing.com Canada
Solventum (SOLV) Q1 2026 Earnings Transcript - AOL.com
Solventum (SOLV) tops Q1 earnings and revenue estimates - MSN
Research Alert: CFRA Maintains Hold On Shares Of Solventum Corporation - Moomoo
Solventum executives take the stage at BofA health conference May 13 - Stock Titan
Solventum to Participate in the 2026 BofA Securities Health Care Conference - marketscreener.com
Wells Fargo Keeps Their Hold Rating on Solventum Corporation (SOLV) - The Globe and Mail
Solventum Bets On 20 Product Launches To Power Post-3M Growth - Citeline News & Insights
Solventum Beats Consensus Estimates for 1Q26 - Medical Device and Diagnostic industry
Solventum (SOLV) Q1 Earnings Slump As Margin Compression Tests Bullish Narratives - simplywall.st
Solventum Corp. stock rises Wednesday, outperforms market - MarketWatch
Solventum gains after activist Trian sends letter urging changes (update) - MSN
Solventum Stock Down Despite Q1 Earnings & Revenues Beat Estimates - Zacks Investment Research
UBS Adjusts Price Target on Solventum to $78 From $82, Maintains Neutral Rating - marketscreener.com
Solventum (SOLV) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance
Solventum (SOLV) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Solventum : Shareholder Letter Q1 2026 - marketscreener.com
Research Alert: Solventum: Broad-based Q1 Growth, Guidance Maintained - Moomoo
Solventum: Q1 Earnings Snapshot - theheraldreview.com
SOLV Q1 Deep Dive: Portfolio Moves and Product Launches Shape Year Ahead - FinancialContent
Solventum Q1 FY26 slides: earnings beat amid portfolio transformation By Investing.com - Investing.com India
Solventum (SOLV) Q1 2026 Earnings Call Transcript - Fortune
Solventum Corporation Q1 2026 Financial Results and Highlights – SEC 10-Q Filing - Minichart
Assessing Solventum (SOLV) Valuation After Recent Share Price Rebound And Product Pipeline Progress - simplywall.st
Solventum Earnings Call Signals Margin Momentum Ahead - TipRanks
Solventum posts Q1 sales, adjusted EPS beats - MassDevice
Solventum outlines EPS toward high end of $6.40-$6.60 range while expecting $100M-$120M annual tariff headwinds - MSN
Solventum Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Solventum forecasts annual profit at higher end on wound care demand - WHTC
Solventum Q1 FY26 slides: earnings beat amid portfolio transformation - Investing.com
Transcript : Solventum Corporation, Q1 2026 Earnings Call, May 05, 2026 - marketscreener.com
Solventum : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Solventum’s Wound-Care Demand Lifts Profit Outlook, Not Its Stock - Finimize
Solventum (SOLV) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Solventum (SOLV) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Solventum Q1 2026 Earnings Call: Complete Transcript - Benzinga
Solventum Corp 1Q 2026: Revenue $2.01B, Net income $13M, EPS $0.07— 10-Q Summary - TradingView
Profits slide as Solventum (NYSE: SOLV) faces tariffs, restructuring and weak cash flow - Stock Titan
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum Corporation 2026 Q1ResultsEarnings Call Presentation (NYSE:SOLV) 2026-05-05 - Seeking Alpha
Solventum Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Solventum Q1 Adjusted Earnings Rise, Sales Decline - marketscreener.com
Solventum : Quarterly Financial Update Q1 2026 - marketscreener.com
Solventum (NYSE:SOLV) Exceeds Q1 CY2026 Expectations - StockStory
Solventum Corp (NYSE:SOLV) Shares Flat After Q1 Beat - ChartMill
SOLVENTUM ($SOLV) Releases Q1 2026 Earnings - Quiver Quantitative
Solventum (SOLV) Q4 2025 Earnings Call Transcript - Fortune
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):